235 related articles for article (PubMed ID: 26763650)
21. CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma.
Li Y; Yu HP; Zhang P
Hepatol Int; 2016 May; 10(3):488-92. PubMed ID: 26643668
[TBL] [Abstract][Full Text] [Related]
22. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
[TBL] [Abstract][Full Text] [Related]
23. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
Peng YF; Shi YH; Ding ZB; Ke AW; Gu CY; Hui B; Zhou J; Qiu SJ; Dai Z; Fan J
Autophagy; 2013 Dec; 9(12):2056-68. PubMed ID: 24157892
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells.
Chen W; Li M; Cheng H; Yan Z; Cao J; Pan B; Sang W; Wu Q; Zeng L; Li Z; Xu K
Cell Biochem Biophys; 2013; 67(3):1181-91. PubMed ID: 23712865
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
[TBL] [Abstract][Full Text] [Related]
26. Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma.
Li T; Zhao S; Song B; Wei Z; Lu G; Zhou J; Huo T
Eur J Med Res; 2015 May; 20(1):56. PubMed ID: 26003220
[TBL] [Abstract][Full Text] [Related]
27. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.
Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF
Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models.
Li GC; Ye QH; Dong QZ; Ren N; Jia HL; Qin LX
Oncol Rep; 2013 Feb; 29(2):713-9. PubMed ID: 23232668
[TBL] [Abstract][Full Text] [Related]
29. Endothelial cell‑derived CCL15 mediates the transmigration of fibrocytes through the CCL15‑CCR1 axis in vitro.
Pang N; Lin Z; Wang X; Xu L; Xu X; Huang R; Li X; Li X; Li J
Mol Med Rep; 2020 Dec; 22(6):5339-5347. PubMed ID: 33174007
[TBL] [Abstract][Full Text] [Related]
30. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B Virus X Protein Modulates Chemokine CCL15 Upregulation in Hepatocellular Carcinoma.
Li Y; Wang C; Zhao T; Cui R; Hu L; Chang L; Wei X; Zhang J; Li Y
Anticancer Agents Med Chem; 2021 Oct; 21(16):2198-2203. PubMed ID: 33653254
[TBL] [Abstract][Full Text] [Related]
32. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression.
Yang X; Lu P; Fujii C; Nakamoto Y; Gao JL; Kaneko S; Murphy PM; Mukaida N
Int J Cancer; 2006 Apr; 118(8):1869-76. PubMed ID: 16284949
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo.
Zhang J; Hou L; Wu X; Zhao D; Wang Z; Hu H; Fu Y; He J
Mol Cell Biochem; 2016 May; 416(1-2):193-203. PubMed ID: 27142531
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
35. Identification of serum CCL15 in hepatocellular carcinoma.
Li Y; Wu J; Zhang W; Zhang N; Guo H
Br J Cancer; 2013 Jan; 108(1):99-106. PubMed ID: 23321514
[TBL] [Abstract][Full Text] [Related]
36. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
37. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
38. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.
Hwang J; Kim CW; Son KN; Han KY; Lee KH; Kleinman HK; Ko J; Na DS; Kwon BS; Gho YS; Kim J
FEBS Lett; 2004 Jul; 570(1-3):47-51. PubMed ID: 15251437
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs.
Park KH; Lee TH; Kim CW; Kim J
J Immunol; 2013 Jun; 190(12):6550-8. PubMed ID: 23690481
[TBL] [Abstract][Full Text] [Related]
40. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
Rubie C; Frick VO; Wagner M; Rau B; Weber C; Kruse B; Kempf K; Tilton B; König J; Schilling M
Scand J Immunol; 2006 Jun; 63(6):468-77. PubMed ID: 16764701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
